Search Results (1,017)

Background: Educational workplace dietary interventions have emerged as a promising approach to supporting occupational well-being among healthcare professionals. This scoping review mapped and synthesized the available evidence on such interventions across healthcare settings. Methods: A scoping review was conducted in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines. PubMed, Scopus, and the Cochrane Library were searched for studies published between December 2020 and March 2026. Thirteen studies met the predefined eligibility criteria. Results: Across the included studies, healthcare professionals exhibited irregular eating patterns, meal skipping, and suboptimal dietary behaviours associated with occupational stress. Educational workplace interventions combining nutrition education with behavioural, organizational, and lifestyle components were associated with improved nutrition knowledge, dietary behaviours, selected health indicators, and occupational well-being. Thematic synthesis identified workplace organization, behavioural determinants, and organizational support as key influences on dietary practices and professional well-being. Conclusions: Workplace nutrition should be considered an integral component of occupational health rather than solely an individual lifestyle behaviour. The proposed Workplace Nutritional Resilience framework highlights the potential contribution of educational, behavioural, and organizational strategies to occupational well-being. Further longitudinal and intervention studies in specific healthcare professions are warranted, particularly among dental professionals. Full article

Background: Precision nutrition and nutrigenomics have emerged as promising strategies to personalize dietary interventions according to individual genetic, metabolic, and molecular characteristics. However, the potential of nutrigenomic-guided nutraceutical interventions to modulate biological aging pathways remains poorly characterized. Objective: This study aimed to map and synthesize the available evidence from human studies evaluating personalized nutraceutical interventions based on nutrigenomic approaches and their effects on biomarkers associated with biological aging. Methods: A scoping review was conducted following the Joanna Briggs Institute methodology and PRISMA-ScR guidelines. PubMed/MEDLINE, Embase, Scopus, and Web of Science were searched for studies published between 2021 and 2026. Eligible studies included adults aged ≥18 years receiving personalized nutraceutical interventions informed by genetic, genomic, metabolomic, or other molecular data. Outcomes included biomarkers of cellular aging, inflammation, oxidative stress, immunometabolism, and related pathways. Results: Twenty-one studies were included. Interventions involved omega-3 fatty acids, polyphenols, Nigella sativa, vitamin D, methyl-donor micronutrients, fermented papaya preparation, and other nutraceutical preparations and functional food-based interventions. Four major themes emerged: multi-omic stratification approaches, biological aging biomarkers, redox-inflammatory modulation, and applications in metabolic disorders. Most studies demonstrated favorable effects on intermediate molecular biomarkers, including inflammatory cytokines, oxidative stress markers, lipid metabolism, endothelial function, and DNA methylation signatures. However, evidence directly demonstrating slowing of biological aging through validated biomarkers such as epigenetic clocks or telomere dynamics remains limited. Conclusions: Personalized nutraceutical interventions exhibit biological plausibility for modulating pathways associated with healthy aging. Nevertheless, robust longitudinal studies incorporating validated biomarkers of biological aging and clinically meaningful outcomes are needed before their widespread implementation in precision medicine. Full article

Glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have transformed obesity management by producing substantial, sustained weight loss and improving metabolic health. Alongside these benefits, their effects on appetite, food intake, and gastrointestinal function have raised increasing interest in the nutritional consequences of pharmacologically induced weight loss. Although reductions in energy intake contribute to therapeutic efficacy, they may also influence protein intake, dietary quality, micronutrient adequacy, and skeletal muscle health, particularly in individuals with pre-existing nutritional vulnerability. This narrative review summarizes current evidence regarding nutritional considerations during GLP-1-based therapy, including changes in dietary intake, protein and micronutrient adequacy, body composition, muscle health, and nutritional assessment. Particular attention is given to populations at increased nutritional risk, practical approaches to nutritional monitoring, and strategies to support adequate nutrition during treatment. Current evidence suggests that nutritional responses to GLP-1-based therapy are heterogeneous and cannot be adequately evaluated using body weight alone. Assessment of dietary intake, body composition, muscle function, physical performance, and individual clinical characteristics provides a more comprehensive understanding of nutritional status than anthropometric measures alone. While routine supplementation or intensive monitoring is not supported for all patients, a risk-based and individualized approach appears appropriate, particularly for older adults and individuals with sarcopenic obesity, previous bariatric surgery, chronic gastrointestinal disease, or persistent treatment-related gastrointestinal symptoms. Future research should establish clinically meaningful nutritional outcomes and determine which nutritional interventions improve patient-centered outcomes during long-term obesity management. Full article

Background/Objectives: Obesity is a chronic, progressive, and relapsing disease that requires long-term, multidisciplinary management rather than episodic weight-loss treatment. Although novel incretin-based anti-obesity pharmacotherapies, including GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists, have markedly improved the clinical management of obesity, weight reduction alone does not fully capture treatment success. Body composition, lean mass preservation, physical function, nutritional adequacy, psychological well-being, adherence, and long-term weight-loss maintenance are increasingly recognized as essential therapeutic outcomes. This narrative review critically examines the role of lifestyle medicine as a co-therapeutic strategy during modern anti-obesity pharmacotherapy, with particular attention to physical activity, nutrition, behavioral support, and individualized monitoring. Methods: A narrative literature search was conducted in PubMed up to June 2026. The review included studies addressing adults with overweight or obesity and evidence related to anti-obesity pharmacotherapy, physical activity, nutrition, body composition, functional outcomes, eating behavior, quality of life, treatment tolerability, adherence, weight regain, and long-term maintenance. Results: Current evidence indicates that incretin-based therapies produce substantial and clinically meaningful weight loss, but pharmacological efficacy may be limited by reductions in lean mass, gastrointestinal adverse events, inadequate nutritional intake, treatment discontinuation, and weight regain after drug withdrawal. Physical activity should be considered a therapeutic component rather than only a tool for increasing energy expenditure, as aerobic exercise supports cardiometabolic health and cardiorespiratory fitness, while resistance training helps preserve muscle strength, bone health, and functional capacity. Nutritional strategies are equally important, particularly during appetite suppression, to maintain adequate protein, fiber, fluids, micronutrients, and diet quality. Behavioral factors, including sleep, stress, mood, stigma, self-regulation, and the food environment, may influence adherence and long-term outcomes. Conclusions: Novel anti-obesity drugs should not be viewed as replacements for lifestyle medicine but as powerful tools within an integrated chronic-care model. The goal of treatment should move beyond maximal body-weight reduction to durable improvements in body composition, metabolic health, physical function, nutritional status, quality of life, and weight-loss maintenance. Full article

Atopic dermatitis (AD) and food allergy frequently coexist during early childhood and are increasingly linked through interactions within the gut–skin axis. We evaluated the clinical outcomes of an integrated nutritional and microbiome-oriented management strategy in children with food allergy-associated AD under real-world conditions. This prospective, two-center, real-world observational cohort study included 85 children (median age, 11 months) with AD diagnosed according to the Hanifin–Rajka criteria and confirmed IgE- and/or non-IgE-mediated food allergy. Participants received individualized nutritional and microbiome-oriented management comprising elimination diets, conventional topical therapy, microbiome-directed interventions, and nutritional supplementation tailored to their clinical, allergological, and microbiological profile. Disease severity was assessed using the Scoring Atopic Dermatitis (SCORAD) index at baseline and after approximately 1 and 3 months of follow-up. Cow’s milk, egg, and wheat were the predominant food allergens, and 69.4% of children were polyallergic. SCORAD decreased significantly during follow-up, with a mean relative reduction of 51.6% and 63.5% of participants achieving a SCORAD50 response. Food allergy burden independently predicted baseline disease severity, whereas documented gut dysbiosis was associated with polyallergy and greater absolute clinical improvement, although this association lost statistical significance after adjustment for baseline disease severity and should therefore not be interpreted as a favorable prognostic effect of dysbiosis. Baseline SCORAD remained the strongest independent predictor of clinical improvement. Integrated nutritional and microbiome-oriented management was associated with substantial clinical improvement and may represent a valuable adjunct to standard care in children with food allergy-associated AD. Because of the observational, uncontrolled design, these findings describe associations rather than causal treatment effects. These findings support further evaluation of personalized nutritional strategies in randomized controlled trials. Full article

Obesity is a complex, multifactorial chronic disease characterized by excessive and/or aberrant adiposity that requires interventions beyond conventional calorie-restriction models. Current clinical guidelines converge on behavioral modification, encompassing nutritional therapy, physical activity, stress reduction, and sleep improvement, as the cornerstone of obesity management, with psychological therapy, pharmacotherapy, and bariatric procedures as adjunctive or escalating options. While traditional “one-size-fits-all” dietary approaches frequently yield suboptimal long-term outcomes, precision nutrition has emerged as a promising strategy for individualized obesity care. This review critically appraises the evidence underlying each pillar of precision nutrition: genetic profiling shows clear utility in monogenic obesity but variable benefit when diet is matched to common polygenic variants; microbiome-targeted studies reveal that the Bacillota to Bacteroidota ratio shows inconsistent associations with obesity across studies, with genus-level and functional alterations offering more reproducible targets; and metabolomic profiling of postprandial glycemic responses has progressed from foundational predictive algorithms to large-scale clinical validation. It also highlights chrono-nutrition, the alignment of food timing with individual chronotype, as an emerging pillar of personalization. Beyond dietary composition, the review addresses how personalized nutrition can mitigate the adverse effects of incretin-based pharmacotherapy and discusses how artificial intelligence can integrate multi-omics and behavioral data into real-time dietary guidance. Future clinical implementation will require overcoming challenges related to data integration, predictive accuracy, and accessibility, paving the way for more effective, evidence-based obesity management. Full article

Provision of cow–calf contact (CCC) in combination with pair housing may enhance welfare and stimulate greater intake of both milk and starter feed, thereby improving the performance and health of calves reared under cold conditions. This study was conducted to investigate the effects of combining partial daily CCC (5 h/d) with pair housing (19 h/d) in dairy calves reared in outdoor pens during winter, when the mean ambient temperature was 6.2 ± 0.4 °C throughout the study period. A total of 30 Holstein calves (birth weight = 37.4 ± 3.4 kg) were enrolled at birth. Fourteen calves received daily dam contact and were pair-housed (DC-PH), while the remaining 16 calves had no dam contact (NC); of these, 8 were pair-housed (NC-PH) and 8 were individually housed (NC-IH). Dam contact was maintained until day 60, after which all calves were weaned and group-housed until day 80. Milk consumption was greater in DC than NC calves (7.4 vs. 5.5 L/d). During the pre-weaning period, body weight and average daily gain did not differ between treatments. However, DC-PH calves had greater body weight at day 80 and higher average daily gain between days 60 and 80 than NC-PH calves (p = 0.01 and p = 0.02, respectively). Pre-weaning starter feed intake and feed efficiency did not differ across treatment groups. Dry matter digestibility was significantly greater in NC-PH than in NC-IH calves (87.7% vs. 81.4%; p = 0.03), but no significant effects were observed on NDF and DM digestibility between NC-PH and DC-PH calves. On day 54 (the pre-weaning phase), compared with NC-PH calves, DC-PH calves had higher blood glucose (p = 0.05), lower cortisol (p = 0.02), tended to have lower βHBA concentrations (p = 0.06), and a greater ruminal protozoal count on day 35 (p = 0.01). Total health score tended to be higher in DC-PH than NC-PH calves (p = 0.06) and was higher in NC-IH than in NC-PH calves (p = 0.05). During an 8-h behavioral recording prior to weaning, DC-PH calves were observed less frequently performing non-nutritive oral behaviors, such as licking the stall or fences and sucking on other calves, and tended to be more frequently standing, contacting other calves, playing alone, walking, and ruminating than NC-PH calves. After weaning, DC-PH calves were observed more frequently eating, resting, walking, and engaging in social interactions than NC-PH calves. Likewise, after weaning, NC-IH calves were observed more frequently playing, vocalizing, and walking, but less eating than NC-PH calves. Overall, our findings indicated that while social interaction (NC-IH vs. NC-PH) significantly improved dry matter digestibility and health, the addition of dam contact (DC-PH) maintained nutrient digestibility at levels comparable to NC-PH, but tended to reduce health status. Also, calves in the DC-PH treatment, which voluntarily consumed more milk than NC calves, exhibited greater post-weaning growth, more favorable behavioral responses, and improved pre-weaning metabolic profiles (lower cortisol and βHBA concentrations and higher blood glucose). These findings indicate that the partial dam contact management system, together with greater voluntary milk intake, was associated with enhanced post-weaning performance and metabolic status, as well as differences in rumen microbial development. However, as milk intake was not standardized across treatments, these responses cannot be attributed solely to maternal contact. Overall, under the conditions of this study, partial dam contact represents a feasible management strategy to support calf welfare and development, provided that appropriate environmental management is implemented to minimize disease risks. Full article

Pleurotus ostreatus (shimeji) is an edible mushroom widely recognized for its nutritional value and production of bioactive compounds. In addition to its fruiting body, mycelial biomass has emerged as a promising and sustainable alternative to produce bioactive compounds under controlled cultivation conditions. This study evaluated the nutritional composition, texture profile, biochemical composition, phenolic compounds, and antioxidant properties of the mycelium of P. ostreatus. Nutritional parameters were determined by FoodScan™ (NIR), while biochemical composition was assessed through spectrophotometric quantification of soluble proteins, free amino acids, reducing sugars, and total carbohydrates. Texture Profile Analysis (TPA) was performed to characterize the mechanical and technological properties of the mycelial biomass. Total phenolic compounds were quantified using the Folin–Ciocalteu method, and individual phenolics were identified by HPLC-DAD. Antioxidant activity was evaluated by ABTS, DPPH, TEAC, and hydroxyl radical scavenging assays. The mycelium exhibited high moisture content and relevant protein levels, as well as a rigid structural profile characterized by elevated hardness and gumminess. Biochemical characterization revealed considerable concentrations of soluble proteins and free amino acids, together with detectable levels of reducing sugars and total carbohydrates. The aqueous extract showed high total phenolic content and expressive antioxidant activity, with gallic acid identified as the predominant phenolic compound, followed by ferulic acid. The extracts also demonstrated efficient radical scavenging capacity in ABTS, DPPH, and hydroxyl radical assays. These findings highlight P. ostreatus mycelium as a sustainable source of bioactive compounds with potential applications as a functional ingredient in food, nutraceutical, and biotechnology sectors, reinforcing its role within circular bioeconomy strategies. Full article

Background: Incretin-based therapies (IBTs), including glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists (GIP/GLP-1 RAs), have transformed the management of obesity and type 2 diabetes mellitus (T2DM). Although these agents provide substantial metabolic and cardiometabolic benefits, their effects on skeletal muscle, particularly in older adults at increased risk of sarcopenia and functional decline, remain incompletely understood. Methods: This narrative review synthesizes evidence from randomized controlled trials (RCTs) and observational studies evaluating the effects of semaglutide and tirzepatide on skeletal muscle mass (SMM), muscle quality, strength, and physical performance. Current evidence on nutritional and exercise strategies aimed at preserving skeletal muscle during IBT was also reviewed. Results: Both semaglutide and tirzepatide induce substantial weight loss accompanied by reductions in lean body mass (LBM). However, current evidence indicates that LBM loss is generally proportional to the magnitude of weight loss and should not be interpreted as a direct surrogate for skeletal muscle loss or drug-induced myotoxicity. Tirzepatide appears to improve skeletal muscle composition by reducing muscle fat infiltration (MFI), whereas semaglutide shows more heterogeneous effects on muscle strength and physical performance, particularly in older or frail individuals. Emerging evidence highlights the importance of muscle quality, nutritional adequacy, and resistance exercise as key determinants of muscle preservation, although functional outcomes and data in older adults remain limited. Conclusions: The effects of incretin-based therapies (IBTs) on skeletal muscle are multifactorial and influenced by age, baseline muscle reserve, nutritional status, and physical activity. Preserving skeletal muscle health should be considered an integral component of obesity management through individualized nutritional care, adequate protein intake, resistance exercise, and regular functional assessment. Future research should prioritize the standardized evaluation of muscle quality and function and determine whether targeted nutritional interventions can improve the quality of weight loss and support healthy aging during IBT. Full article

While individual Si-nutrient interactions have been reviewed separately, a comparative analysis of multiple Si-element interactions remains lacking. This review compares current knowledge on co-application of Si with selenium (Se), sulphur (S), zinc (Zn) and iron (Fe), focusing on stress tolerance, nutrient homeostasis, physiological responses, secondary metabolism and agronomic relevance. The evidence indicates that combining Si with these elements helps maintain reactive oxygen species (ROS) homeostasis, strengthen antioxidant defenses, stabilize photosynthetic function and improve nutrient uptake, translocation and use efficiency. Responses depend on plant species, nutrient form, application strategy and environmental conditions; at the metabolic level, Si-based combinations affect the synthesis of phenolic compounds, amino acids and sulphur-containing metabolites. Si-Se and Si-Fe proved most effective under heavy-metal stress, through regulation of metal transport, detoxification and sequestration, and Si-S and Si-Zn under drought, salinity and nutrient-deficient conditions, by enhancing osmotic adjustment, nutrient-use efficiency, ionic homeostasis and photosynthetic performance. Agronomically, these interactions can increase crop productivity, nutritional value and biofortification potential, and mitigate toxic-element accumulation in edible parts. Knowledge gaps remain regarding molecular regulation, variability among species and environments, and the long-term effectiveness of nanoparticle formulations. Since most evidence comes from hydroponic, pot and greenhouse studies, standardized field experiments are needed to assess agronomic relevance. Full article

For decades, industrial trans fatty acids (iTFAs) have remained a critical focus of the scientific community, the food industry, and regulatory authorities because of their well-established role in the development of cardiovascular diseases, metabolic disorders, and chronic systemic inflammation. Rather than providing a descriptive overview, this review critically synthesizes current evidence on the elimination of industrial TFAs by integrating health, technological, regulatory, and sustainability perspectives into a comprehensive interdisciplinary analysis. The review outlines the biochemical characteristics and dietary sources of trans fatty acid isomers, highlighting the continuing scientific debate regarding the differential health effects of industrially produced and naturally occurring ruminant-derived TFAs. It also examines the evolution of scientific evidence that led to major regulatory actions by international organizations, including the World Health Organization (WHO) and the European Commission, resulting in legally binding restrictions that have substantially reduced industrial TFA intake and improved public health. Particular emphasis is placed on the critical assessment of current fat reformulation strategies, considering not only their technological functionality but also their nutritional quality, long-term metabolic implications, and contribution to sustainable food systems. Full hydrogenation, fractionation, chemical and enzymatic interesterification, and oleogelation are comparatively evaluated with respect to their advantages, limitations, and potential technological, nutritional, and environmental trade-offs. In addition, lipid microencapsulation is discussed as an emerging strategy for protecting oxidation-sensitive polyunsaturated fatty acids (PUFAs), thereby facilitating their incorporation into functional foods while maintaining nutritional quality. Unlike previous reviews that primarily focus on health outcomes or individual processing technologies, this review systematically integrates the sustainability dimensions of alternative fat modification approaches, including resource efficiency, energy consumption, clean label product development, and circular economy principles. Furthermore, it identifies current knowledge gaps related to the long-term metabolic safety, industrial scalability, and environmental performance of emerging lipid technologies. By combining these complementary perspectives, the review provides a comprehensive interdisciplinary synthesis that supports evidence-based fat reformulation and offers practical guidance for researchers, food manufacturers, and policy makers seeking to develop safer, nutritionally improved, technologically functional, and environmentally sustainable lipid systems. Full article

Within the emerging field of nutritional neuroscience, omega-3 fatty acids are among the most extensively investigated dietary bioactive compounds with potential relevance to cognitive aging. As populations continue to age worldwide, identifying modifiable nutritional factors that support cognitive health has become an important public health priority. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), obtained primarily from marine sources, are integral components of neuronal membranes and serve as precursors of specialized pro-resolving lipid mediators. This narrative review integrates concepts from nutritional neuroscience and geroscience to examine how dietary omega-3 fatty acids may influence biological pathways involved in age-related cognitive decline. Current evidence suggests that DHA and EPA affect multiple processes linked to brain aging, including neuroinflammation, synaptic plasticity, mitochondrial function, oxidative stress, cerebrovascular integrity, cellular senescence, and gut–brain axis signaling. These mechanisms overlap with several hallmarks of aging and may contribute to the maintenance of cognitive function during later life. Observational studies generally associate higher dietary intake or circulating omega-3 status with better cognitive performance and a lower risk of cognitive decline and dementia. Findings from randomized controlled trials are less consistent, although benefits appear more likely in individuals with low baseline omega-3 status, mild cognitive impairment, or increased biological vulnerability. Beyond their established anti-inflammatory effects, omega-3 fatty acids may influence multiple aging-related pathways, particularly inflammaging, vascular aging, and mitochondrial dysfunction. Although heterogeneity in study design, dosage, intervention timing, and participant characteristics precludes firm conclusions, viewing omega-3 fatty acids through a geroscience lens offers a useful framework for interpreting existing evidence and informing future research. Overall, omega-3 fatty acids represent a promising nutritional strategy for supporting cognitive health across the lifespan, warranting further investigation in well-characterized populations and precision nutrition approaches. Full article

Background: Ultra-processed food (UPF) consumption may be associated not only with nutrition knowledge but also with individuals’ practical food-related competencies and overall dietary patterns. Aim: This study investigated how cooking and food skills, dietary literacy, and adherence to the Mediterranean diet were related to UPF consumption among adults in İstanbul, Türkiye. Methods: This descriptive cross-sectional study included 293 (85.7% female, mean age of 22.63 ± 4.66 years) adults residing in Istanbul, Türkiye between 1 January 2026 and 30 June 2026. Data were collected through an online questionnaire comprising sociodemographic and food-related characteristics, the Cooking Skills and Food Skills Measure, the e-Healthy Diet Literacy Scale (e-HDL), the Mediterranean Diet Adherence Screener (MEDAS), and the Short Screening Questionnaire of Highly Processed Food Consumption (sQ-HPF). Validated Turkish versions of all instruments were used; no measurement tool was developed specifically for this study. Results: 57.0% of participants were classified as having a high level of UPF consumption. The high level of UPF consumption group was younger, cooked at home less frequently, ordered food more frequently, and had lower cooking skills, food skills, and MEDAS scores compared to the low level of UPF consumption group (all p < 0.05). UPF consumption was negatively correlated with food skills (r: −0.33), MEDAS (r = −0.28), cooking skills (r = −0.27), age (r = −0.21), and home-cooking frequency (r = −0.18) and positively correlated with food-ordering frequency (r = 0.18). In the final regression model, younger age (β = −0.144, p = 0.009), lower food skills (β = −0.325, p < 0.001), and lower MEDAS scores (β = −0.252, p < 0.001) were independently associated with higher UPF consumption. E-HDL was not independently associated with UPF consumption. The final model explained 18.4% of the adjusted variance. Conclusions: Among this predominantly young and female sample of adults residing in Istanbul, lower food skills and lower Mediterranean diet adherence co-occurred with higher UPF consumption. Although the direction of these associations cannot be determined, the findings may inform future strategies that integrate nutrition education with practical food preparation support and the promotion of Mediterranean-style food choices. Full article

Poultry nutrition simultaneously affects animal health, productive efficiency, product quality and the environmental burdens associated with feed production and manure management. Nutritional interventions may generate synergies among these outcomes, but they can also shift costs or environmental impacts across biological and supply-chain boundaries. This review critically evaluates low-protein diets, functional additives, feed enzymes, alternative protein sources, precision-feeding technologies and nutritional approaches to manure-emission mitigation. The evidence indicates that improved intestinal function and nutrient retention can reduce feed requirements and nutrient excretion, whereas excessive protein restriction, unstable additive responses, limited alternative-ingredient supply and poorly validated digital systems may compromise performance, product quality or economic feasibility. Environmental benefits are also sensitive to ingredient origin, processing, transport, crystalline amino acid and additive manufacture, coproduct allocation and life cycle assessment assumptions. To integrate these considerations, we propose a four-level conceptual decision framework comprising physiological adequacy, precision nutrient supply, constraint-specific functional intervention and whole-chain verification. The framework treats health, productive performance, product quality, economic feasibility and environmental impact as simultaneous decision criteria, while genotype, production stage, disease pressure, climate, ingredient availability and market objectives define the conditions of application. Standardized life cycle assessment and commercial validation are required to distinguish reproducible net benefits from improvements confined to individual indicators. This approach provides a structured basis for selecting poultry nutritional strategies that remain biologically effective, economically accessible and environmentally beneficial under practical production conditions. Full article

Background: Beetroot-derived nitrate supplementation is a widely studied nutritional strategy to enhance athletic performance. Although ergogenic benefits have been reported in recreational and moderately trained individuals, evidence for highly trained and elite athletes remains inconsistent. Objectives: This scoping review aimed to map and synthesize evidence from randomized controlled trials (RCTs) investigating the effects of beetroot-derived nitrate supplementation on performance, recovery, and physiological outcomes in highly trained and elite athletes. Methods: The review followed the Joanna Briggs Institute methodology and PRISMA-ScR guidelines. Literature searches were conducted in PubMed, Scopus, and Web of Science. Eligible studies included RCTs involving McKay Tier 3–5 athletes and evaluating beetroot-derived nitrate supplementation as a standalone intervention. Results: Thirty-one RCTs met the inclusion criteria, representing athletes from a wide range of sports. Supplementation protocols varied substantially, with nitrate doses ranging from 4 to 19.5 mmol·day⁻¹ (248–1209 mg·day⁻¹) and durations from acute administration to 15 days. Positive effects were most frequently reported for cycling time-trial performance, Yo-Yo intermittent recovery performance, anaerobic power, neuromuscular performance, exercise tolerance, and recovery. In contrast, findings for endurance performance, sport-specific skills, oxygen consumption, and perceptual responses were inconsistent despite marked increases in nitrate and nitrite bioavailability. The outcomes seemed to depend on dosage, duration, sport type, and athletes’ training status. Conclusions: Beetroot-derived nitrate supplementation may enhance performance in highly trained and elite athletes, particularly during high-intensity and anaerobic activities. However, the effects are inconsistent, underscoring the need for further research to establish optimal supplementation strategies and evaluate long-term efficacy in elite sporting populations. Full article